Trine Meldgaard Lund

15PUBLICATIONS
46CO-AUTHORS
Haematological tumoursCharacterisation of biological macromoleculesPharmacogenomicsPredictive and prognostic markersPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 18, 2026
Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications.

|May 28, 2026
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients.

|Sep 20, 2025
Population pharmacokinetic modelling revealed large variability in oromucosal absorption of Δ9-tetrahydrocannabinol in older patients with poor appetite.

Ida Klitzing Storgaard, Rikke Lundsgaard Nielsen, Morten Baltzer Houlind

|Sep 08, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients.

Tianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann

|Feb 19, 2025
Predictive Biomarkers and Personalized Therapy: Use of Pharmacogenetic Testing in a Scandinavian Perspective.

Niels Westergaard, Trine Meldgaard Lund, Charlotte Vermehren

|Nov 07, 2024
Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic review.

Cathrine Korsholm, Cille Bülow, Mikkel Christensen

Pageof 3

Frequent Collaborators

4 joint publications

Kim Dalhoff

3 joint publications

Anna Sofie Buhl Rasmussen

3 joint publications

Kjeld Schmiegelow

3 joint publications

Cecilie Utke Rank